| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |